FDA panel is first key test for Biden COVID-19 booster plan

  • by

WASHINGTON (AP) — The Biden administration’s embattled plan to dispense COVID-19 booster shots to most Americans faced its first major hurdle Friday as a government advisory panel met to decide whether to endorse extra doses of the Pfizer vaccine.

Leave a Reply

Your email address will not be published. Required fields are marked *